Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Aclaris Therapeutics Inc (NASDAQ: ACRS) was $2.47 for the day, up 0.41% from the previous closing price of $2.46. In other words, the price has increased by $0.41 from its previous closing price. On the day, 1.66 million shares were traded. ACRS stock price reached its highest trading level at $2.47 during the session, while it also had its lowest trading level at $2.325.
Ratios:
Our analysis of ACRS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.03 and its Current Ratio is at 7.03. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Leerink Partners Upgraded its Market Perform to Outperform on November 19, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRS now has a Market Capitalization of 264336928 and an Enterprise Value of 50957428. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.76 while its Price-to-Book (P/B) ratio in mrq is 1.36. Its current Enterprise Value per Revenue stands at 1.882 whereas that against EBITDA is -0.819.
Stock Price History:
The Beta on a monthly basis for ACRS is 0.53, which has changed by 1.1293104 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is -17.39%, while the 200-Day Moving Average is calculated to be 49.48%.
Shares Statistics:
ACRS traded an average of 2.46M shares per day over the past three months and 826600 shares per day over the past ten days. A total of 107.02M shares are outstanding, with a floating share count of 89.49M. Insiders hold about 16.38% of the company’s shares, while institutions hold 50.49% stake in the company. Shares short for ACRS as of 1734048000 were 3162546 with a Short Ratio of 1.45, compared to 1731628800 on 1559255. Therefore, it implies a Short% of Shares Outstanding of 3162546 and a Short% of Float of 3.3099998.
